Stephenie Lucas, MD
General Practice · Saint Clair Shores, MINPI 1023116068
Payments from drug & device makers
Across 78 payments — averaging $18.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$336
- AstraZeneca$202
- Sanofi-aventis U.S. LLC$140
- Ascensia Diabetes Care US Inc.$100
- Novo Nordisk$97
- Medtronic$93
- plus $501 from 19 others
What the payments were for
- Food & beverage$1,35892%
- Education$1118%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 20 | $336 |
| AstraZeneca | 13 | $202 |
| Sanofi-aventis U.S. LLC | 8 | $140 |
| Ascensia Diabetes Care US Inc. | 1 | $100 |
| Novo Nordisk | 6 | $97 |
| Medtronic(2 entities) | 5 | $93 |
| Medline Industries LP | 1 | $53 |
| Valeritas, Inc. | 1 | $52 |
| Shire North American Group Inc | 2 | $45 |
| Mannkind Corporation | 3 | $39 |
| Pfizer | 2 | $32 |
| Amarin Pharma, Inc. | 2 | $30 |
| BD | 2 | $29 |
| Boehringer Ingelheim | 1 | $25 |
| Averitas Pharma Inc. | 1 | $24 |
| Zealand Pharma US, Inc. | 1 | $23 |
| Biodelivery Sciences International, Inc. | 1 | $21 |
| Insulet Corporation | 1 | $19 |
| MDD US Operations, LLC | 1 | $19 |
| Abbott | 1 | $17 |
| Azurity Pharmaceuticals, Inc. | 1 | $16 |
| Johnson & Johnson | 1 | $15 |
| Arbor Pharmaceuticals, Inc. | 1 | $15 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $14 |
| GRT US Holding, Inc. | 1 | $13 |
How this compares
$1,469 in reported general payments places this provider in the 85th percentile of 3,051 general practice providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Losartan Potassium | 29 | $503 |
| Rosuvastatin Calcium | 29 | $427 |
| Atorvastatin Calcium | 15 | $282 |
| Amlodipine Besylate | 23 | $175 |
| Tramadol Hcl | 14 | $39 |
Paid to pharmacies, not to this prescriber.
Other general practice in Saint Clair Shores
- Anil PrasadTaylor$1.7M
- Sadeer DaoodDearborn$1.1M
- Shakib HalabuWest Bloomfield$1.1M
- Dennis FasbinderAnn Arbor$758K
- Christian GrothAnn Arbor$283K
- Kevin BoneSaginaw$125K
- David JulianiRochester Hills$106K
- Marie FluentAnn Arbor$106K
- Howard KormanRoyal Oak$93K
- Hans SchwarzSterling Heights$88K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.